Clinical Trials on Breast Tumour
Total 30361 results
-
Emory UniversityNovartis; Eisai Inc.TerminatedBreast Cancer | Breast Neoplasms | Breast TumorsUnited States
-
Universitaire Ziekenhuizen KU LeuvenTerminatedNeuroendocrine Tumors | Neural Crest TumorBelgium
-
University of MichiganCompleted
-
Hospital Universitari de BellvitgeRecruiting
-
Oslo University HospitalNorwegian Cancer Society; KlinbeforskActive, not recruitingBreast Cancer | Breast Neoplasms | Hormone Receptor Positive TumorNorway
-
Pamela MunsterQuantumLeap Healthcare CollaborativeTerminatedTriple Negative Metastatic Breast Cancer | BRCA-mutated Solid TumorUnited States
-
Samsung Medical CenterRecruitingTriple Negative Breast Cancer | Pembrolizumab | Neoadjuvant Chemotherapy | Tumor MicroenvironmentKorea, Republic of
-
Washington University School of MedicineAclaris Therapeutics, Inc.WithdrawnAdvanced Solid Tumor | Advanced Solid Tumor MalignanciesUnited States
-
Zhongnan HospitalCompletedDesflurane | Propofol | Breast Tumor | Postoperative Sleep | PSQIChina
-
Zhiyong YuUnknownBreast Cancer | Circulating Tumor DNA | Neoadjuvant ChemotherapyChina
-
RenJi HospitalRecruitingBreast Cancer | Circulating Tumor CellChina
-
University of JenaUniversity Hospital Erlangen; Labor Prof. PachmannRecruiting
-
Peking Union Medical College HospitalNot yet recruitingBreast Diseases | Metastatic Breast Cancer | HER2-positive Breast Cancer | Hormone Receptor Positive Malignant Neoplasm of Breast | Breast Cancer Female | Hormone Receptor Positive Tumor
-
Washington University School of MedicineNational Institute for Biomedical Imaging and Bioengineering (NIBIB)CompletedBreast Cancer | Breast Tumors | Cancer of Breast | Malignant Neoplasm of Breast | Cancer of the BreastUnited States
-
Fuzhou General HospitalNot yet recruitingBreast Diseases | Metastatic Breast Cancer | HER2-positive Breast Cancer | Hormone Receptor Positive Malignant Neoplasm of Breast | Breast Cancer Female | Hormone Receptor Positive TumorChina
-
National Cancer Institute (NCI)RecruitingSolid Tumor | Refractory Solid Tumors | Malignant Solid Tumors | Other Neoplasms Solid Tumors | Pediatric Solid TumorUnited States
-
Universitair Ziekenhuis BrusselKom Op Tegen KankerRecruitingBreast Cancer | Melanoma (Skin) | Malignant Solid TumorBelgium
-
GE HealthcareCompletedBreast Cancer | Cancer Screening | Tumors, BreastUnited States
-
University of Southern CaliforniaNational Cancer Institute (NCI)RecruitingCancer | Metastatic | Breast | Triple Negative | Disseminated Tumor CellUnited States
-
Blaze Bioscience Inc.Completed
-
University Hospital, Basel, SwitzerlandETH Zurich - The Aceto LabCompletedBreast Cancer | Circulating Tumor Cells (CTCs)Switzerland
-
Emory UniversityCompletedBreast Cancer | Breast Neoplasms | Breast Tumors | Neoplasms, Breast | Cancer of Breast | Cancer of the Breast | Human Mammary CarcinomaUnited States
-
Case Comprehensive Cancer CenterNational Cancer Institute (NCI)CompletedBreast Cancer | Unspecified Adult Solid Tumor, Protocol SpecificUnited States
-
National Institutes of Health Clinical Center (CC)National Cancer Institute (NCI)CompletedBreast Cancer | Unspecified Adult Solid Tumor, Protocol SpecificUnited States
-
University of SaskatchewanActive, not recruitingBreast Cancer | Hormone Receptor Positive Tumor | Premenopausal Breast CancerCanada
-
Acrotech Biopharma Inc.CompletedBreast Cancer | Breast Tumors | Neoplasms, Breast | Cancer of the Breast | Human Mammary CarcinomaFrance, United States, Czechia, Hungary
-
MedSIRPfizerCompletedBreast Cancer | Advanced Breast Cancer | Hormone Receptor Positive Tumor | Human Epidermal Growth Factor 2 Negative Carcinoma of BreastSpain, Germany, France, United Kingdom, Italy, Slovenia
-
University of ArizonaNational Cancer Institute (NCI)CompletedStage IV Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast Cancer | Estrogen Receptor-positive Breast Cancer | Progesterone Receptor Positive TumorUnited States
-
Institut Claudius RegaudActive, not recruitingTriple Negative Breast Cancers Without Lymph-node Involvement and < or = 30 mmFrance
-
Jules Bordet InstituteRecruiting
-
RenJi HospitalBeijing Viroad Biotechnology Co., Ltd.CompletedLocally Advanced Breast Cancer | Circulating Tumor CellChina
-
Dartmouth-Hitchcock Medical CenterTerminatedBreast CancerUnited States
-
Institut Català d'OncologiaAmgenActive, not recruitingStage I Breast Cancer | Breast Neoplasm Female | Stage II Breast Cancer | Hormone Receptor Positive Tumor | Hormone Receptor Negative NeoplasmSpain
-
Barbara Ann Karmanos Cancer InstituteWashington University School of MedicineRecruitingBreast Cancer | Rectal Cancer | Neuroendocrine Tumors | Metastatic Brain Tumor | Intracranial GliomaUnited States
-
Sichuan Baili Pharmaceutical Co., Ltd.SystImmune Inc.; Baili-Bio (Chengdu) Pharmaceutical Co., Ltd.RecruitingBreast Cancer | Locally Advanced or Metastatic Solid TumorChina
-
Spectrum Pharmaceuticals, IncTerminatedBreast Cancer | Colorectal Cancer | Solid Tumor | Glioblastome MultiformeUnited States
-
Hebei Medical University Fourth HospitalNot yet recruiting
-
H. Lee Moffitt Cancer Center and Research InstituteNational Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol Specific | Male Breast Cancer | Stage IV Breast Cancer | Recurrent Breast CancerUnited States
-
National Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol Specific | Recurrent Melanoma | Recurrent Bladder Cancer | Stage IV Bladder Cancer | Male Breast Cancer | Stage IV Breast Cancer | Stage IV Melanoma | Recurrent Breast Cancer | Stage III MelanomaUnited States
-
Yonsei UniversityTerminated
-
Universitätsmedizin MannheimCompletedBreast Cancer | TumorsGermany
-
UNICANCERBreast International GroupCompletedBreast Cancer | Menopause | Estrogen Receptor Positive Tumor | Hormone AntagonistFrance, Sweden, Spain
-
US Oncology ResearchMillennium Pharmaceuticals, Inc.Active, not recruitingBreast Cancer | Breast Tumors | Breast Carcinoma | Malignant Neoplasm of BreastUnited States
-
Gilead SciencesRecruitingStudy of Sacituzumab Govitecan (SG) in Japanese Participants With Advanced Solid Tumors (ASCENT-J02)Advanced Solid Tumor | Metastatic Urothelial Cancer | Metastatic Triple-Negative Breast Cancer | HR+/HER2- Metastatic Breast CancerJapan
-
Taiho Oncology, Inc.CompletedAdvanced Solid Tumors (Excluding Breast Cancer)United States
-
XU ZhiPeking UniversityUnknownBreast Tumor | Thyroid TumorChina
-
Novartis PharmaceuticalsCompletedAdvanced Solid Tumors, Excluding Breast CancerUnited States
-
Thomas HatschekActive, not recruitingEarly-Stage Breast Carcinoma | Estrogen Receptor Positive TumorSweden
-
NBE-Therapeutics AGCmed Clinical ServicesTerminatedTriple Negative Breast Cancer | Advanced Solid Tumor | Advanced CancerUnited States
-
iOMEDICO AGNovartis PharmaceuticalsCompletedBreast Cancer | Hormone Receptor Positive Tumor | HER 2 Negative Breast CancerGermany